HIGH-DOSE MELPHALAN DOSAGE ADJUSTMENT - POSSIBILITY OF USING A TEST-DOSE

被引：0
|
作者：
TRANCHAND, B
PLOIN, YD
MINUIT, MP
SAPET, C
BIRON, P
PHILIP, T
ARDIET, C
机构：
来源：
CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1989年 / 23卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：95 / 100
页数：6
相关论文
共 50 条
  • [1] DOSAGE PREDICTIONS IN HIGH-DOSE METHOTREXATE INFUSIONS .1. EVALUATION OF THE CLASSIC TEST-DOSE PROTOCOL
    CANO, JP
    BRUNO, R
    LENA, N
    FAVRE, R
    ILIADIS, A
    IMBERT, AM
    [J]. CANCER DRUG DELIVERY, 1985, 2 (04): : 271 - 276
  • [2] Validation of a test-dose strategy prior intravenous melphalan in children with renal failure undergoing high-dose chemotherapy with autologous stem cell transplantation
    Dourthe, M. E.
    Poinsignon, V.
    Dufour, C.
    Broutin, S.
    Tod, M.
    Konecki, C.
    Guitton, J.
    Valteau-Couanet, D.
    Paci, A.
    [J]. BONE MARROW TRANSPLANTATION, 2016, 51 : S239 - S240
  • [3] DOSAGE ADJUSTMENT OF HIGH-DOSE METHOTREXATE IN ADULT OSTEOSARCOMA
    PIGNON, T
    LACARELLE, B
    GUILLET, P
    DUFFAUD, F
    CATALIN, J
    DURAND, A
    FAVRE, R
    [J]. BULLETIN DU CANCER, 1994, 81 (11) : 976 - 978
  • [4] Test-dose pharmacokinetics guided melphalan dose adjustment in reduced intensity conditioning allogeneic transplant for non-malignant disorders
    Chandra, Sharat
    Mizuno, Kana
    Zhao, Junfang
    Davies, Stella M.
    Marsh, Rebecca A.
    Fukuda, Tsuyoshi
    Setchell, Kenneth D. R.
    Vinks, Alexander A.
    Mehta, Parinda A.
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (01) : 115 - 127
  • [5] USE OF A TEST-DOSE OF METHOTREXATE TO PREDICT INDIVIDUAL PATIENT PHARMACOKINETICS AND DOSE MODIFICATION OF HIGH-DOSE METHOTREXATE INFUSIONS
    KERR, IG
    JOLIVET, J
    COLLINS, JM
    GIANNI, L
    DRAKE, J
    MYERS, CE
    CHABNER, BA
    [J]. CLINICAL RESEARCH, 1982, 30 (02): : A533 - A533
  • [6] STUDIES WITH HIGH-DOSE MELPHALAN
    MCELWAIN, T
    [J]. CANCER TREATMENT REVIEWS, 1979, 6 : 149 - 150
  • [7] Individual dosage adjustment of high-dose methotrexate in clinical practice
    BagarryLiegey, D
    Nicoara, A
    Duffaud, F
    Guillet, P
    Pignon, T
    Catalin, J
    Durand, A
    Favre, R
    [J]. REVUE DE MEDECINE INTERNE, 1996, 17 (08): : 689 - 698
  • [8] DOSAGE PREDICTIONS IN HIGH-DOSE METHOTREXATE (HD-MTX) INFUSION - EVALUATION OF THE CLASSICAL TEST-DOSE (TD) PROTOCOL AND BAYESIAN-ESTIMATION (BE) IMPROVEMENTS
    BRUNO, R
    IMBERT, AM
    ILIADIS, A
    FAVRE, R
    LENA, N
    CATALIN, J
    CARCASSONNE, Y
    CANO, JP
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 37 (02) : 184 - 184
  • [9] Pharmacodynamics of High-Dose Melphalan in Myeloma
    Nath, C. E.
    Joshua, D.
    Kerridge, I.
    Kwan, Y. L.
    Shaw, P. J.
    Trotman, J.
    Zeng, L.
    Presgrave, P.
    Tiley, C.
    McLachlan, A.
    Gurney, H.
    Earl, J.
    [J]. CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S34 - S35
  • [10] Encephalopathy complicating high-dose melphalan
    A Schuh
    J Dandridge
    P Haydon
    TJ Littlewood
    [J]. Bone Marrow Transplantation, 1999, 24 : 1141 - 1143
12345